Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years: A randomized trial

Li Min Huang; Thanyawee Puthanakit; Chiu Cheng-Hsun; Tang Ren-Bin; Tino Schwarz; Angelo Pellegrino; Susanna Esposito; Louise Frenette; Shelly McNeil; Paolo Durando; Paul Rheault; Carlo Giaquinto; Michael Horn; Karl Ulrich Petry; Klaus Peters; Toma Azhar; Peter Hillemanns; Stephanie De Simoni; Damien Friel; Suryakiran Pemmaraju; Marjan Hezareh; Florence Thomas; Dominique Descamps; Nicolas Folschweiller; Frank Struyf

doi:10.1093/infdis/jix154

Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years: A randomized trial

Li Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, Tang Ren-Bin, Tino Schwarz, Angelo Pellegrino, Susanna Esposito, Louise Frenette, Shelly McNeil, Paolo Durando, Paul Rheault, Carlo Giaquinto, Michael Horn, Karl Ulrich Petry, Klaus Peters, Toma Azhar, Peter Hillemanns, Stephanie De Simoni, Damien Friel, Suryakiran PemmarajuMarjan Hezareh, Florence Thomas, Dominique Descamps, Nicolas Folschweiller, Frank Struyf

Decision Sciences

Research output: Contribution to journal › Article › peer-review

29 Citations (Scopus)

Original language	English
Pages (from-to)	1711-1719
Number of pages	9
Journal	Journal of Infectious Diseases
Volume	215
Issue number	11
DOIs	https://doi.org/10.1093/infdis/jix154
Publication status	Published - Jun 1 2017

ASJC Scopus Subject Areas

Infectious Diseases
Immunology and Allergy

Keywords

2-dose schedule
Cervarix
Cervical cancer
Human papillomavirus (HPV)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/infdis/jix154

Cite this

Huang, L. M., Puthanakit, T., Cheng-Hsun, C., Ren-Bin, T., Schwarz, T., Pellegrino, A., Esposito, S., Frenette, L., McNeil, S., Durando, P., Rheault, P., Giaquinto, C., Horn, M., Petry, K. U., Peters, K., Azhar, T., Hillemanns, P., De Simoni, S., Friel, D., ... Struyf, F. (2017). Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years: A randomized trial. Journal of Infectious Diseases, 215(11), 1711-1719. https://doi.org/10.1093/infdis/jix154

Huang, LM, Puthanakit, T, Cheng-Hsun, C, Ren-Bin, T, Schwarz, T, Pellegrino, A, Esposito, S, Frenette, L, McNeil, S, Durando, P, Rheault, P, Giaquinto, C, Horn, M, Petry, KU, Peters, K, Azhar, T, Hillemanns, P, De Simoni, S, Friel, D, Pemmaraju, S, Hezareh, M, Thomas, F, Descamps, D, Folschweiller, N & Struyf, F 2017, 'Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years: A randomized trial', Journal of Infectious Diseases, vol. 215, no. 11, pp. 1711-1719. https://doi.org/10.1093/infdis/jix154

@article{d80a5d37887c4885b157a6608048aa49,

title = "Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years: A randomized trial",

keywords = "2-dose schedule, Cervarix, Cervical cancer, Human papillomavirus (HPV)",

author = "Huang, {Li Min} and Thanyawee Puthanakit and Chiu Cheng-Hsun and Tang Ren-Bin and Tino Schwarz and Angelo Pellegrino and Susanna Esposito and Louise Frenette and Shelly McNeil and Paolo Durando and Paul Rheault and Carlo Giaquinto and Michael Horn and Petry, {Karl Ulrich} and Klaus Peters and Toma Azhar and Peter Hillemanns and {De Simoni}, Stephanie and Damien Friel and Suryakiran Pemmaraju and Marjan Hezareh and Florence Thomas and Dominique Descamps and Nicolas Folschweiller and Frank Struyf",

note = "Publisher Copyright: {\textcopyright} The Author 2017.",

year = "2017",

month = jun,

day = "1",

doi = "10.1093/infdis/jix154",

language = "English",

volume = "215",

pages = "1711--1719",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "11",

}

TY - JOUR

T1 - Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years

T2 - A randomized trial

AU - Huang, Li Min

AU - Puthanakit, Thanyawee

AU - Cheng-Hsun, Chiu

AU - Ren-Bin, Tang

AU - Schwarz, Tino

AU - Pellegrino, Angelo

AU - Esposito, Susanna

AU - Frenette, Louise

AU - McNeil, Shelly

AU - Durando, Paolo

AU - Rheault, Paul

AU - Giaquinto, Carlo

AU - Horn, Michael

AU - Petry, Karl Ulrich

AU - Peters, Klaus

AU - Azhar, Toma

AU - Hillemanns, Peter

AU - De Simoni, Stephanie

AU - Friel, Damien

AU - Pemmaraju, Suryakiran

AU - Hezareh, Marjan

AU - Thomas, Florence

AU - Descamps, Dominique

AU - Folschweiller, Nicolas

AU - Struyf, Frank

PY - 2017/6/1

Y1 - 2017/6/1

KW - 2-dose schedule

KW - Cervarix

KW - Cervical cancer

KW - Human papillomavirus (HPV)

UR - http://www.scopus.com/inward/record.url?scp=85029152634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029152634&partnerID=8YFLogxK

U2 - 10.1093/infdis/jix154

DO - 10.1093/infdis/jix154

M3 - Article

C2 - 28591778

AN - SCOPUS:85029152634

SN - 0022-1899

VL - 215

SP - 1711

EP - 1719

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 11

ER -

Sustained immunogenicity of 2-dose human papillomavirus 16/18 AS04-adjuvanted vaccine schedules in girls aged 9-14 years: A randomized trial

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this